CGVBX
Price
$27.46
Change
-$0.01 (-0.04%)
Updated
Oct 14 closing price
Net Assets
18.66B
CWIAX
Price
$74.87
Change
-$0.12 (-0.16%)
Updated
Oct 14 closing price
Net Assets
140.74B
Interact to see
Advertisement

CGVBX vs CWIAX

Header iconCGVBX vs CWIAX Comparison
Open Charts CGVBX vs CWIAXBanner chart's image
American Funds Global Insight 529-C
Price$27.46
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets18.66B
American Funds Capital World Gr&Inc 529A
Price$74.87
Change-$0.12 (-0.16%)
VolumeN/A
Net Assets140.74B
CGVBX vs CWIAX Comparison Chart in %
View a ticker or compare two or three
VS
CGVBX vs. CWIAX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGVBX is a Hold and CWIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 141B vs. CGVBX (18.7B). CWIAX pays higher dividends than CGVBX: CWIAX (1.39) vs CGVBX (0.06). CGVBX was incepted earlier than CWIAX: CGVBX (6 years) vs CWIAX (24 years). CGVBX (1.60) is less costly to investors than CWIAX (0.78). CWIAX is a more actively managed with annual turnover of: 27.00 vs. CGVBX (21.00). CGVBX (250) and CWIAX (250) have matching initial minimum investment requirements. CGVBX annual gain was more profitable for investors over the last year : 13.45 vs. CWIAX (9.68). CGVBX return over 5 years is better than : 57.42 vs. CWIAX (53.97).
CGVBXCWIAXCGVBX / CWIAX
Total Expense Ratio1.600.78205%
Annual Report Gross Expense Ratio1.600.78205%
Fund Existence6 years24 years-
Gain YTD18.41319.62394%
Front LoadN/A4%-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets18.7B141B13%
Annual Yield % from dividends0.061.394%
Returns for 1 year13.459.68139%
Returns for 3 years69.9572.6196%
Returns for 5 years57.4253.97106%
Returns for 10 yearsN/A98.56-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA14.090.93
+7.07%
Ginkgo Bioworks Holdings
CMMB3.450.09
+2.68%
Chemomab Therapeutics Ltd
WDS14.45-0.03
-0.21%
Woodside Energy Group Limited
FTLF20.05-0.10
-0.50%
FitLife Brands Inc
APGE52.37-1.60
-2.96%
Apogee Therapeutics